Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease-Reference-Cited by-同舟云学术

Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease

Published:2019 Issue:26 Volume:55 Page:3765-3768
ISSN:1359-7345
Container-title:Chemical Communications
language:en
Short-container-title:Chem. Commun.

Author:

Meden Anže¹²³⁴⁵,Knez Damijan⁵²³⁴,Jukič Marko⁵²³⁴,Brazzolotto Xavier⁶⁷⁸^ORCID,Gršič Marija¹²³⁴,Pišlar Anja⁵²³⁴,Zahirović Abida⁵²³⁴^ORCID,Kos Janko⁵²³⁴⁹,Nachon Florian⁶⁷⁸,Svete Jurij¹²³⁴^ORCID,Gobec Stanislav⁵²³⁴,Grošelj Uroš¹²³⁴^ORCID

Affiliation:

1. Faculty of Chemistry and Chemical Technology

2. University of Ljubljana

3. SI-1000 Ljubljana

4. Slovenia

5. Faculty of Pharmacy

6. Institut de Recherche Biomédicale des Armées

7. 91223 Brétigny sur Orge

8. France

9. Jožef Stefan Institute

Abstract

Tryptophan-derived selective nanomolar butyrylcholinesterase inhibitors with great potential for symptomatic therapy against Alzheimer's disease are disclosed.

Funder

Javna Agencija za Raziskovalno Dejavnost RS

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Metals and Alloys,Surfaces, Coatings and Films,General Chemistry,Ceramics and Composites,Electronic, Optical and Magnetic Materials,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2019/CC/C9CC01330J

Reference18 articles.

1. Alzheimer's disease

2. The history of the cholinergic hypothesis

3. Treatment of Alzheimer's disease; current status and new perspectives

4. Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients

5. Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amelioration potential of synthetic oxime chemical cores against multiple sclerosis and Alzheimer's diseases: Evaluation in aspects of in silico and in vitro experiments;Journal of Molecular Structure;2024-12

2. Dynamic interchange between two protonation states is characteristic of active sites of cholinesterases;Protein Science;2024-07-18

3. Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents;Molecules;2024-05-03

4. Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer’s Disease;ACS Chemical Neuroscience;2024-03-07

5. Green approach to the synthesis of α-aminophosphonate-tetrahydroisoquinoline hybrids and their anti-cholinesterase activity;Bioorganic Chemistry;2024-02